Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | August 1, 1997 |
| Phase: | Phase I |
| Status: | Active, not recruiting |
| NCT ID: | NCT00006216 |
| Study Type: | Interventional |
| Intervention: | Biological: PA-1-STK ovarian carcinoma vaccine|Drug: ganciclovir |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Stanley S. Scott Cancer Center at Louisiana State University Medical Center - New Orleans |
| Ages: | Child|Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other |
| First Received: | September 11, 2000 |
| End Date: | |
| Last Updated: | February 6, 2009 |
| Last Verified: | July 1, 2001 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
